Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04156893 · ClinicalTrials.gov registry record · Phase 1
RH Genotype Matched RBC Transfusions
A Phase 1 study of Sickle Cells Disease, sponsored by Children's Hospital of Philadelphia.
- Recruiting
- Registry status
- Phase 1
- Development phase
- 35
- Enrollment target
- 1
- Study location
NCT04156893 is a Phase 1 study of Sickle Cells Disease that is actively recruiting participants, run by Children's Hospital of Philadelphia. The registered enrollment target is 35 participants. The trial reports 1 study location across 1 state.
The verdict
NCT04156893, a Phase 1 study of Sickle Cells Disease, is actively recruiting participants, sponsored by Children's Hospital of Philadelphia.
- RECRUITING
- Registry status
- Phase 1
- Development phase
- 35 participants
- Enrollment target
- 1
- Study location
Study Summary
To determine the feasibility and efficacy of matching donor red cells by RH genotype for a cohort of chronically transfused patients with SCD.
Conditions Studied
Interventions
- BIOLOGICAL Red cell units that are genotype matched at the RHD and RHCE loci
Study Locations (1)
Pennsylvania
- Children's Hospital of Philadelphia - Philadelphia
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 35 participants |
| Start Date | 2020-01-30 |
| Est. Completion | 2029-10 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04156893
The ClinicalTrials.gov registry entry for NCT04156893 describes a study currently listed as recruiting, categorized as Phase 1. The registered enrollment target is 35 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Children's Hospital of Philadelphia, which has 431 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Sickle Cells Disease appearing as the primary indexed condition, and to 1 intervention - of which Red cell units that are genotype matched at the RHD and RHCE loci is the first listed.
NCT04156893 reports 1 study location spanning 1 distinct geographic area - top geographies include Pennsylvania.
Frequently Asked Questions
What is clinical trial NCT04156893 about?
NCT04156893 is a clinical study titled "RH Genotype Matched RBC Transfusions". To determine the feasibility and efficacy of matching donor red cells by RH genotype for a cohort of chronically transfused patients with SCD.
What is the current status of trial NCT04156893?
This trial is currently recruiting. It is a Phase 1 study. The enrollment target is 35 participants. The study started on 2020-01-30. Estimated completion is 2029-10.
What conditions does trial NCT04156893 study?
This clinical trial studies the following conditions: Sickle Cells Disease.
What interventions are being tested in trial NCT04156893?
The interventions under investigation include: Red cell units that are genotype matched at the RHD and RHCE loci (BIOLOGICAL).
Who is sponsoring clinical trial NCT04156893?
This trial is sponsored by Children's Hospital of Philadelphia, which has 431 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04156893 being conducted?
This trial has 1 study location across Pennsylvania. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.